-
1
-
-
42349084468
-
Fungal infections in hematopoietic stem cell transplant recipients
-
Marr KA. Fungal infections in hematopoietic stem cell transplant recipients. Med Mycol. 2008; 46: 293-302.
-
(2008)
Med Mycol
, vol.46
, pp. 293-302
-
-
Marr, K.A.1
-
2
-
-
39449095735
-
Treatment of aspergillosis: clinical practice guideline of the infectious diseases society of America
-
Walsh TJ, Anaissie EJ, Denning DW, Herbrecht R, Kontoyiannis DP, Marr KA, Morrison VA, Segal BH, Steinbach WJ, Stevens DA, van Burik JA, Wingard JR, Patterson TF. Treatment of aspergillosis: clinical practice guideline of the infectious diseases society of America. Clin Infect Dis. 2008; 46: 327-60.
-
(2008)
Clin Infect Dis
, vol.46
, pp. 327-360
-
-
Walsh, T.J.1
Anaissie, E.J.2
Denning, D.W.3
Herbrecht, R.4
Kontoyiannis, D.P.5
Marr, K.A.6
Morrison, V.A.7
Segal, B.H.8
Steinbach, W.J.9
Stevens, D.A.10
van Burik, J.A.11
Wingard, J.R.12
Patterson, T.F.13
-
3
-
-
4544236836
-
Combination antifungal therapy for invasive aspergillosis
-
Marr KA, Boeckh M, Carter RA, Kim HW, Corey L. Combination antifungal therapy for invasive aspergillosis. Clin Infect Dis. 2004; 39: 797-802.
-
(2004)
Clin Infect Dis
, vol.39
, pp. 797-802
-
-
Marr, K.A.1
Boeckh, M.2
Carter, R.A.3
Kim, H.W.4
Corey, L.5
-
4
-
-
1442275740
-
Combination antifungal therapy
-
Johnson MD, MacDougall C, Ostrosky-Zeichner L, Perfect JR, Rex JH. Combination antifungal therapy. Antimicrob Agents Chermother. 2004; 48: 693-715.
-
(2004)
Antimicrob Agents Chermother
, vol.48
, pp. 693-715
-
-
Johnson, M.D.1
Macdougall, C.2
Ostrosky-Zeichner, L.3
Perfect, J.R.4
Rex, J.H.5
-
5
-
-
68849085666
-
Anidulafungin and voriconazole in invasive fungal disease: pharmacological data and their use in combination
-
Perkhofer S, Lass-Flörl C. Anidulafungin and voriconazole in invasive fungal disease: pharmacological data and their use in combination. Expert Opin Investig Drugs. 2009; 18: 1393-404.
-
(2009)
Expert Opin Investig Drugs
, vol.18
, pp. 1393-1404
-
-
Perkhofer, S.1
Lass-Flörl, C.2
-
6
-
-
79952321919
-
In vitro and in vivo efficacy of anidulafungin in murine infections by Aspergillus flavus
-
Calvo E, Pastor FJ, Mayayo E, Salas V, Guarro J. In vitro and in vivo efficacy of anidulafungin in murine infections by Aspergillus flavus. Antimicrob Agents Chemother. 2011; 55: 1290-2.
-
(2011)
Antimicrob Agents Chemother
, vol.55
, pp. 1290-1292
-
-
Calvo, E.1
Pastor, F.J.2
Mayayo, E.3
Salas, V.4
Guarro, J.5
-
7
-
-
80052264675
-
Efficacy of anidulafungin against Aspergillus niger in vitro and in vivo
-
Calvo E, Pastor FJ, Mayayo E, Guarro J. Efficacy of anidulafungin against Aspergillus niger in vitro and in vivo. Int J Antimicrob Agents. 2011; 38: 360-3.
-
(2011)
Int J Antimicrob Agents
, vol.38
, pp. 360-363
-
-
Calvo, E.1
Pastor, F.J.2
Mayayo, E.3
Guarro, J.4
-
8
-
-
79958813535
-
Lessons from animal studies for the treatment of invasive human infections due to uncommon fungi
-
Guarro J. Lessons from animal studies for the treatment of invasive human infections due to uncommon fungi. J Antimicrob Chemother. 2011; 66: 1447-66.
-
(2011)
J Antimicrob Chemother
, vol.66
, pp. 1447-1466
-
-
Guarro, J.1
-
9
-
-
44849086424
-
Anidulafungin: experimental therapy of fungal infections in animal models
-
Pastor FJ, Guarro J. Anidulafungin: experimental therapy of fungal infections in animal models. Rev Iberoam Micol. 2008; 25: 119-23.
-
(2008)
Rev Iberoam Micol
, vol.25
, pp. 119-123
-
-
Pastor, F.J.1
Guarro, J.2
-
10
-
-
33750553597
-
The safety of anidulafungin
-
Vazquez JA. The safety of anidulafungin. Expert Opin Drug Saf. 2006; 5: 751-8.
-
(2006)
Expert Opin Drug Saf
, vol.5
, pp. 751-758
-
-
Vazquez, J.A.1
-
11
-
-
80053253460
-
-
Laboratory Clinical Standards Institute, Reference Method for Broth Dilution Antifungal Susceptibility Testing of Filamentous Fungi. Approved Standard-Second Edition, Wayne, PA: Clinical and Laboratory Standards Institute
-
Laboratory Clinical Standards Institute. Reference method for broth dilution antifungal susceptibility testing of filamentous fungi. Approved Standard-Second Edition. CLSI document M38-A2. Wayne, PA: Clinical and Laboratory Standards Institute; 2008.
-
(2008)
CLSI Document M38-A2
-
-
-
12
-
-
1442300127
-
In vitro evaluation of double and triple combinations of antifungal drugs against Aspergillus fumigatus and Aspergillus terreus
-
Dannaoui E, Lortholary O, Dromer F. In vitro evaluation of double and triple combinations of antifungal drugs against Aspergillus fumigatus and Aspergillus terreus. Antimicrob Agents Chemother. 2004; 48: 970-8.
-
(2004)
Antimicrob Agents Chemother
, vol.48
, pp. 970-978
-
-
Dannaoui, E.1
Lortholary, O.2
Dromer, F.3
-
13
-
-
0035162902
-
In vitro susceptibility testing methods for caspofungin against Aspergillus and Fusarium isolates
-
Arikan S, Lozano-Chiu M, Paetznick V, Rex JH. In vitro susceptibility testing methods for caspofungin against Aspergillus and Fusarium isolates. Antimicrob Agents Chemother. 2001; 45: 327-30.
-
(2001)
Antimicrob Agents Chemother
, vol.45
, pp. 327-330
-
-
Arikan, S.1
Lozano-Chiu, M.2
Paetznick, V.3
Rex, J.H.4
-
14
-
-
12744273574
-
Pharmacokinetics/pharmacodynamics of echinocandins
-
Theuretzbacher U. Pharmacokinetics/pharmacodynamics of echinocandins. Eur J Microbiol Infect Dis. 2004; 23: 805-12.
-
(2004)
Eur J Microbiol Infect Dis
, vol.23
, pp. 805-812
-
-
Theuretzbacher, U.1
-
15
-
-
33845356887
-
Comparative in vivo activity of BAL4815, the active component of the prodrug BAL8557, in a neutropenic murine model of disseminated Aspergillus flavus
-
Warn PA, Sharp A, Mosquera J, Spickermann J, Schimitt-Hoffmann A, Heep M, Denning DW. Comparative in vivo activity of BAL4815, the active component of the prodrug BAL8557, in a neutropenic murine model of disseminated Aspergillus flavus. J Antimicrob Chemother. 2006; 58: 1198-207.
-
(2006)
J Antimicrob Chemother
, vol.58
, pp. 1198-1207
-
-
Warn, P.A.1
Sharp, A.2
Mosquera, J.3
Spickermann, J.4
Schimitt-Hoffmann, A.5
Heep, M.6
Denning, D.W.7
-
16
-
-
0034042868
-
Effect of grapefruit juice on serum voriconazole concentrations in the mouse
-
Sugar AM, Liu XP. Effect of grapefruit juice on serum voriconazole concentrations in the mouse. Med Mycol. 2000; 38: 209-12.
-
(2000)
Med Mycol
, vol.38
, pp. 209-212
-
-
Sugar, A.M.1
Liu, X.P.2
-
17
-
-
27844502515
-
Safety and pharmacokinetics of coadministered voriconazole and anidulafungin
-
Dowell JA, Schranz J, Baruch A, Foster G. Safety and pharmacokinetics of coadministered voriconazole and anidulafungin. J Clin Pharmacol. 2005; 45: 1373-82.
-
(2005)
J Clin Pharmacol
, vol.45
, pp. 1373-1382
-
-
Dowell, J.A.1
Schranz, J.2
Baruch, A.3
Foster, G.4
-
18
-
-
71249104670
-
Bronchopulmonary disposition of intravenous voriconazole and anidulafungin given in combination to healthy adults
-
Crandon JL, Banevicius MA, Fang AF, Crownover PH, Knauft RF, Pope JS, Russomanno JH, Shore E, Nicolau DP, Kuti JL. Bronchopulmonary disposition of intravenous voriconazole and anidulafungin given in combination to healthy adults. Antimicrob Agents Chemother. 2009; 53: 5102-7.
-
(2009)
Antimicrob Agents Chemother
, vol.53
, pp. 5102-5107
-
-
Crandon, J.L.1
Banevicius, M.A.2
Fang, A.F.3
Crownover, P.H.4
Knauft, R.F.5
Pope, J.S.6
Russomanno, J.H.7
Shore, E.8
Nicolau, D.P.9
Kuti, J.L.10
-
19
-
-
0037379397
-
In vitro synergy of caspofungin and itraconazole against Aspergillus spp.: MIC versus minimal effective concentration end points
-
Shalit I, Shadkchan Y, Samra Z, Osherov N. In vitro synergy of caspofungin and itraconazole against Aspergillus spp.: MIC versus minimal effective concentration end points. Antimicrob Agents Chemother. 2003; 47: 1416-8.
-
(2003)
Antimicrob Agents Chemother
, vol.47
, pp. 1416-1418
-
-
Shalit, I.1
Shadkchan, Y.2
Samra, Z.3
Osherov, N.4
-
20
-
-
14744279799
-
Combined activity in vitro of caspofungin, amphotericin B, and azole agents against itraconazole-resistant clinical isolates of Aspergillus fumigatus
-
Cuenca-Estrella M, Gomez-Lopez A, Garcia-Effron G, Alcazar-Fuoli L, Mellado E, Buitrago MJ, Rodriguez-Tudela JL. Combined activity in vitro of caspofungin, amphotericin B, and azole agents against itraconazole-resistant clinical isolates of Aspergillus fumigatus. Antimicrob Agents Chemother. 2005; 49: 1232-5.
-
(2005)
Antimicrob Agents Chemother
, vol.49
, pp. 1232-1235
-
-
Cuenca-Estrella, M.1
Gomez-Lopez, A.2
Garcia-Effron, G.3
Alcazar-Fuoli, L.4
Mellado, E.5
Buitrago, M.J.6
Rodriguez-Tudela, J.L.7
-
21
-
-
28444451092
-
In vitro activity of the echinocandins. How should it be evaluated?
-
Pastor FJ, Guarro J. In vitro activity of the echinocandins. How should it be evaluated? Rev Iberoam Micol. 2005; 22: 133-40.
-
(2005)
Rev Iberoam Micol
, vol.22
, pp. 133-140
-
-
Pastor, F.J.1
Guarro, J.2
-
22
-
-
0035991955
-
Efficacy of caspofungin alone and in combination with voriconazole in a Guinea pig model of invasive aspergillosis
-
Kirkpatrick WR, Perea S, Coco BJ, Patterson TF. Efficacy of caspofungin alone and in combination with voriconazole in a Guinea pig model of invasive aspergillosis. Antimicrob Agents Chemother. 2002; 46: 2564-8.
-
(2002)
Antimicrob Agents Chemother
, vol.46
, pp. 2564-2568
-
-
Kirkpatrick, W.R.1
Perea, S.2
Coco, B.J.3
Patterson, T.F.4
-
23
-
-
0036721037
-
In vitro interaction of caspofungin acetate with voriconazole against clinical isolates of Aspergillus spp
-
Perea S, Gonzalez G, Fothergill AW, Kirkpatrick WR, Rinaldi MG, Patterson TF. In vitro interaction of caspofungin acetate with voriconazole against clinical isolates of Aspergillus spp. Antimicrob Agents Chemother. 2002; 46: 3039-41.
-
(2002)
Antimicrob Agents Chemother
, vol.46
, pp. 3039-3041
-
-
Perea, S.1
Gonzalez, G.2
Fothergill, A.W.3
Kirkpatrick, W.R.4
Rinaldi, M.G.5
Patterson, T.F.6
-
24
-
-
23044509903
-
In vitro synergy testing of anidulafungin with itraconazole, voriconazole, and amphotericin B against Aspergillus spp. and Fusarium spp
-
Philip A, Odabasi Z, Rodriguez J, Paetznick VL, Chen E, Rex JH, Ostrosky-Zeichner L. In vitro synergy testing of anidulafungin with itraconazole, voriconazole, and amphotericin B against Aspergillus spp. and Fusarium spp. Antimicrob Agents Chemother. 2005; 49: 3572-4.
-
(2005)
Antimicrob Agents Chemother
, vol.49
, pp. 3572-3574
-
-
Philip, A.1
Odabasi, Z.2
Rodriguez, J.3
Paetznick, V.L.4
Chen, E.5
Rex, J.H.6
Ostrosky-Zeichner, L.7
-
25
-
-
42949173371
-
Susceptibility testing of anidulafungin and voriconazole alone and in combination against conidia and hyphae of Aspergillus spp. under hypoxic conditions
-
Perkhofer S, Jost D, Dierich MP, Lass-Flörl C. Susceptibility testing of anidulafungin and voriconazole alone and in combination against conidia and hyphae of Aspergillus spp. under hypoxic conditions. Antimicrob Agents Chemother. 2008; 52: 1873-5.
-
(2008)
Antimicrob Agents Chemother
, vol.52
, pp. 1873-1875
-
-
Perkhofer, S.1
Jost, D.2
Dierich, M.P.3
Lass-Flörl, C.4
-
26
-
-
67049086947
-
Combination therapy in treatment of experimental pulmonary aspergillosis: in vitro and in vivo correlations of the concentration- and dose- dependent interactions between anidulafungin and voriconazole by Bliss independence drug interaction analysis
-
Petraitis V, Petraitene R, Hope WW, Meletiadis J, Mickiene D, Hughes JE, Cotton MP, Stergiopoulou T, Kasai M, Francesconi A, Shaufele RL, Sein T, Avila NA, Bacher J, Walsh TJ. Combination therapy in treatment of experimental pulmonary aspergillosis: in vitro and in vivo correlations of the concentration- and dose- dependent interactions between anidulafungin and voriconazole by Bliss independence drug interaction analysis. Antimicrob Agents Chemother. 2009; 53: 2382-91.
-
(2009)
Antimicrob Agents Chemother
, vol.53
, pp. 2382-2391
-
-
Petraitis, V.1
Petraitene, R.2
Hope, W.W.3
Meletiadis, J.4
Mickiene, D.5
Hughes, J.E.6
Cotton, M.P.7
Stergiopoulou, T.8
Kasai, M.9
Francesconi, A.10
Shaufele, R.L.11
Sein, T.12
Avila, N.A.13
Bacher, J.14
Walsh, T.J.15
-
27
-
-
66149156458
-
Combination therapy of advanced invasive pulmonary aspergillosis in transiently neutropenic rats using human pharmacokinetic equivalent doses of voriconazole and anidulafungin
-
van de Sande WW, Mathotten RA, ten Kate MT, van Vianen W, Tavakol M, Rijnders BJ, Bakker-Woudenberg IA. Combination therapy of advanced invasive pulmonary aspergillosis in transiently neutropenic rats using human pharmacokinetic equivalent doses of voriconazole and anidulafungin. Antimicrob Agents Chemother. 2009; 53: 2005-13.
-
(2009)
Antimicrob Agents Chemother
, vol.53
, pp. 2005-2013
-
-
van de Sande, W.W.1
Mathotten, R.A.2
Ten Kate, M.T.3
van Vianen, W.4
Tavakol, M.5
Rijnders, B.J.6
Bakker-Woudenberg, I.A.7
-
28
-
-
6444222945
-
Efficacy of voriconazole plus amphotericin B or micafungin in a guinea-pig model of invasive pulmonary aspergillosis
-
Chandrasekar PH, Cutright JL, Manavathu EK. Efficacy of voriconazole plus amphotericin B or micafungin in a guinea-pig model of invasive pulmonary aspergillosis. Clin Microbiol Infect. 2004; 10: 925-8.
-
(2004)
Clin Microbiol Infect
, vol.10
, pp. 925-928
-
-
Chandrasekar, P.H.1
Cutright, J.L.2
Manavathu, E.K.3
-
29
-
-
24144486212
-
Efficacy of caspofungin and voriconazole combinations in experimental aspergillosis
-
MacCallum DM, Whyte JA, Odds FC. Efficacy of caspofungin and voriconazole combinations in experimental aspergillosis. Antimicrob Agents Chemother. 2005; 49: 3697-701.
-
(2005)
Antimicrob Agents Chemother
, vol.49
, pp. 3697-3701
-
-
Maccallum, D.M.1
Whyte, J.A.2
Odds, F.C.3
-
30
-
-
34848878326
-
Disseminated invasive aspergillosis with cerebral involvement successfully treated with caspofungin and voriconazole
-
Gubler C, Wildi SM, Imhof A, Schneemann M, Müllhaupt B. Disseminated invasive aspergillosis with cerebral involvement successfully treated with caspofungin and voriconazole. Infection. 2007; 35: 364-6.
-
(2007)
Infection.
, vol.35
, pp. 364-366
-
-
Gubler, C.1
Wildi, S.M.2
Imhof, A.3
Schneemann, M.4
Müllhaupt, B.5
-
31
-
-
18244384466
-
Successful antifungal combination therapy with voriconazole and caspofungin
-
Schuster F, Moelter C, Schmid I, Graubner UB, Kammer B, Belohradsky BH, Führer M. Successful antifungal combination therapy with voriconazole and caspofungin. Pediatr Blood Cancer. 2005; 15: 682-5.
-
(2005)
Pediatr Blood Cancer
, vol.15
, pp. 682-685
-
-
Schuster, F.1
Moelter, C.2
Schmid, I.3
Graubner, U.B.4
Kammer, B.5
Belohradsky, B.H.6
Führer, M.7
-
32
-
-
32844474763
-
Combination of voriconazole and caspofungin as primary therapy for invasive aspergillosis in solid organ transplant recipients: a prospective, multicenter, observational study
-
Singh N, Limaye AP, Forrest G, Safdar N, Muñoz P, Pursell K, Houston S, Rosso F, Montoya JG, Patton P, del Busto R, Aguado JM, Fisher RA, Klintmalm GB, Miller R, Wagener MM, Lewis RE, Kontoyiannis DP, Husain S. Combination of voriconazole and caspofungin as primary therapy for invasive aspergillosis in solid organ transplant recipients: a prospective, multicenter, observational study. Transplantation. 2006; 81: 320-6.
-
(2006)
Transplantation
, vol.81
, pp. 320-326
-
-
Singh, N.1
Limaye, A.P.2
Forrest, G.3
Safdar, N.4
Muñoz, P.5
Pursell, K.6
Houston, S.7
Rosso, F.8
Montoya, J.G.9
Patton, P.10
Del Busto, R.11
Aguado, J.M.12
Fisher, R.A.13
Klintmalm, G.B.14
Miller, R.15
Wagener, M.M.16
Lewis, R.E.17
Kontoyiannis, D.P.18
Husain, S.19
-
33
-
-
74349130637
-
Clinical outcomes of lung-transplant recipients treated by voriconazole and caspofungin combination in aspergillosis
-
Thomas A, Korb V, Guillemain R, Caruba T, Boussaud V, Baillaud E, Prognon P, Begué D, Sabatier B. Clinical outcomes of lung-transplant recipients treated by voriconazole and caspofungin combination in aspergillosis. J Clin Pharm Ther. 2010; 35: 49-53.
-
(2010)
J Clin Pharm Ther
, vol.35
, pp. 49-53
-
-
Thomas, A.1
Korb, V.2
Guillemain, R.3
Caruba, T.4
Boussaud, V.5
Baillaud, E.6
Prognon, P.7
Begué, D.8
Sabatier, B.9
|